Literaturverzeichnis

Cozza KL, Amstrong SC, Oesterheld JR (2003), Concise guide to drug interaction, principles for medical practice. Cytochrome P450s, UGTS, P-glycoproteins: p 201 [2340]

Cozza KL, Amstrong SC, Oesterheld JR (2003). Concise guide to drug interaction principles for medical practice. Cytochrome P450s, UGTS, P glycoproteins [2600]

Cozza KL, Amstrong SC, Oesterheld JR, Concise guide to drug interaction. Principles for medical practice. Cytochrome P450s, UGTS, P-glycoproteins, American Psychiatric Publishing, Washington DC (2003) [2733]

Cozza KL, Armstrong SC, Oesterheld JR (2003), Concise guide to drug interaction principles for medical practice. Cytochrome P450s, UGTS, P-glycoproteins: 51, 236 [2559]

Cozza KL. Psychosomatics. Sep 2012; 53(5): 499-502 Pubmed [4193]

Cozzolino et al. Clin Europea (1972) 11, 593 [2382]

Crabtree BL. Am J Psychiatry. Aug 1991; 148(8): 1060-3 Pubmed [1701]

Craig JM. Endocrinology. May 2021; 162(5) Pubmed [10669]

Cranshaw T. Schizophr Bull. Jul 2020; 46(4): 751 Pubmed, Volltext, DOI [9955]

Crass RL. Pharmacotherapy. Feb 2019; 39(2): 182-195 Pubmed [8226]

Crauwels H, 2010. Pharmacokinetic interaction study between TMC278, a next-generation NNRTI, and methadone. Abstract WEPE0089, presented at the XVIII International AIDS Conference, July 18–23, 2010, Vienna, Austria [3412]

Crauwels H. AIDS Rev. Apr 2013; 15(2): 87-101 Pubmed [6553]

Crauwels HM. Int J Clin Pharmacol Ther. Feb 2014; 52(2): 118-28 Pubmed [6556]

Crauwels HM. J Clin Pharmacol. Feb 2014; 54(2): 133-40 Pubmed [6568]

Cravens MG. Cureus. Jan 2019; 11(1): e3827 Pubmed, Volltext, DOI [7162]

Crawford P. CNS Drugs. Jan 2002; 16(4): 263-72 Pubmed [9276]

Crettol S. Clin Pharmacol Ther. Dec 2005; 78(6): 593-604 Pubmed [1832]

Crettol S. Clin Pharmacol Ther. Dec 2006; 80(6): 668-81 Pubmed [146]

Crettol S. Curr Pharm Des. Jan 2010; 16(2): 204-19 Pubmed [5021]

Crewe HK. Biochem Pharmacol. Jan 1997; 53(2): 171-8 Pubmed [4019]

Crewe HK. Br J Clin Pharmacol. Sep 1992; 34(3): 262-5 Pubmed, Volltext [5004]

Crippin JS. Am J Gastroenterol. Apr 1993; 88(4): 590-2 Pubmed [6807]

Croissant B. Am J Drug Alcohol Abuse. Jan 2008; 34(5): 534-40 Pubmed [10641]

Crommentuyn KM. Clin Infect Dis. Apr 2004; 38(8): e73-5 Pubmed [6428]

Cronson AJ. Am J Psychiatry. Jul 1978; 135(7): 856-7 Pubmed [1681]

Cropp JS. Pharmacotherapy. Sep 1997; 17(5): 917-28 Pubmed [4758]

Cropp, J.S. Pharmacotherapy. Volume 17(Issue 5): Pages 917-928 Pubmed [9158]

Cross HM. S Afr Med J. Mar 2018; 108(4): 271-274 Pubmed [7173]

Crowe A. Toxicol Appl Pharmacol. May 2012; 260(3): 294-302 Pubmed [159]

Crowe S. Anesthesiology. Feb 2003; 98(2): 574-5 Pubmed [9849]

Crowley JJ. Clin Pharmacol Ther. Sep 1987; 42(3): 334-40 Pubmed [2734]

Crucitti A. Curr Med Res Opin. Nov 2010; 26(11): 2579-88 Pubmed [12934]

Cruddas L. J Eur Acad Dermatol Venereol. Jun 2017; 31(6): 952-963 Pubmed [6951]

Crussell-Porter LL. Arch Intern Med. Jan 1993; 153(1): 102-4 Pubmed [5892]

Cruz Rodriguez JB. Ann Transl Med. Mar 2021; 9(6): 519 Pubmed [11045]

Csajka C. Clin Pharmacokinet. Dec 2016; 55(12): 1521-1533 Pubmed [7562]

Csik V, Molnar J. Possible adverse interaction between clozapine and ampicillin in an adolescent with schizophrenia. J Child Adolesc Psychopharmacol (1994) 4, 123-8 [1108]

Csuka M. JAMA. May 1986; 255(17): 2315-9 Pubmed [8882]

Cuadrado A et al. Method Find exp Clin Pharmacol (1996) 18 (Suppl C), 65 [717]

Cuadrado A. Eur J Pharmacol. Mar 2003; 465(1-2): 43-52 Pubmed [9500]

Cuadrado A. Pharmacol Res. May 2005; 51(5): 489-96 Pubmed [9321]

Cubeddu Curr Cardiol Rev. 2009 Aug;5(3):166-76.-122 [3083]

Cubeddu LX. Am J Ther. Nov 2003; 10(6): 452-7 Pubmed [7795]

Cubeddu LX. Curr Cardiol Rev. Aug 2009; 5(3): 166-76 Pubmed [12718]

Cudmore J. Can Fam Physician. Jan 2014; 60(1): 53-6 Pubmed, Volltext [5310]

Cuesta Grueso C. Farm Hosp. May 2006; 30(3): 149-53 Pubmed [7267]

Cueva JE. J Am Acad Child Adolesc Psychiatry. Apr 1996; 35(4): 480-90 Pubmed [11701]

Cui C. Curr Drug Metab. Jan 2020; 21(6): 427-435 Pubmed [10786]

Culm-Merdek KE. Br J Clin Pharmacol. Nov 2005; 60(5): 486-93 Pubmed, Volltext, DOI [7699]

Culm-Merdek KE. Clin Pharmacol Ther. Mar 2006; 79(3): 243-54 Pubmed [11683]

Culmsee C. Stroke. May 2004; 35(5): 1197-202 Pubmed [3194]

Cummings JL. CNS Spectr. Feb 2022; 27(1): 7-15 Pubmed [14192]

Cundy KC. Clin Pharmacokinet. Feb 1999; 36(2): 127-43 Pubmed [7095]

Cuñetti L. Transplant Proc. Mar 2018; 50(2): 461-464 Pubmed [13604]

Cunningham D. Am J Emerg Med. Sep 2021 Pubmed [11127]

Cunningham RF. Clin Pharmacokinet. Mar 1981; 6(2): 135-51 Pubmed [7553]

Curis E. Infection. Aug 2015; 43(4): 473-81 Pubmed [5650]

Curran A. Expert Rev Anti Infect Ther. Dec 2011; 9(12): 1115-8 Pubmed [8748]

Curran MP. Drugs. Jan 2010; 70(2): 191-213 Pubmed [4142]

Curry ML, Curry SH, Marroum PJ. Interaction of phenothiazine and related drugs and caffeinated beverages. DICP Ann Pharmacother (1991) 25, 437-8 [857]

Curry MP. N Engl J Med. Dec 2015; 373(27): 2618-28 Pubmed [7903]

Curry SH. Br J Pharmacol. Jul 1971; 42(3): 403-11 Pubmed, Volltext [900]

Curry SH. Eur J Clin Pharmacol. Jan 1985; 29(4): 429-33 Pubmed [528]

Curry SH. Eur J Clin Pharmacol. Jan 1987; 32(3): 317-20 Pubmed [565]

Curtis BR. Immunohematology. Jan 2014; 30(2): 95-101 Pubmed [8144]

Curtis LH. Am J Med. Feb 2003; 114(2): 135-41 Pubmed [4943]

Cusato J. J Antimicrob Chemother. Jun 2018; 73(6): 1659-1664 Pubmed [7206]

Custodio J, West S, Vu A, et al., Lack of clinically relevant effect of bictegravir on metformin pharmacokinetics and pharmacodynamics. Paper presented at: 18th International Workshop on Clinical Pharmacology of Antiviral Therapy; 2017; Chicago, IL. Available from: http://www.natap.org/2017/Pharm/Pharm_32.htm. Accessed May 29, 2018. [7479]

Custodio J, West S, Vu A, et al., Lack of clinically relevant effect of bictegravir on metformin pharmacokinetics and pharmacodynamics. Paper presented at: 18th International Workshop on Clinical Pharmacology of Antiviral Therapy; 2017; Chicago, IL. Available from: http://www.natap.org/2017/Pharm/Pharm_32.htm. Accessed May 29. [7478]

Custodio J, West S, Vu A, et al., Pharmacokinetics of bictegravir administered twice daily with rifampin. Paper presented at: The Conference on Retroviruses and Opportunistic Infections (CROI); 2018; Boston, MA. Available from: http://www.croiconference.org/sessions/ pharmacokinetics-bictegravir-administered-twice-daily-combinationrifampin. Accessed May 29, 2018. [7488]

Custodio J, West S, Vu A, et al., Pharmacokinetics of bictegravir administered twice daily with rifampin. Paper presented at: The Conference on Retroviruses and Opportunistic Infections (CROI); 2018; Boston, MA. Available from: http://www.croiconference.org/sessions/ pharmacokinetics-bictegravir-administered-twice-daily-combinationrifampin. Accessed May 29, 2018. [7489]

Custodio J, West S, Vu A, et al., Pharmacokinetics of bictegravir administered twice daily with rifampin. Paper presented at: The Conference on Retroviruses and Opportunistic Infections (CROI); 2018; Boston, MA. Available from: http://www.croiconference.org/sessions/ pharmacokinetics-bictegravir-administered-twice-daily-combinationrifampin. Accessed May 29, 2018. [7490]

Custodio J, West S, Vu A, et al., Pharmacokinetics of bictegravir administered twice daily with rifampin. Paper presented at: The Conference on Retroviruses and Opportunistic Infections (CROI); 2018; Boston, MA. Available from: http://www.croiconference.org/sessions/ pharmacokinetics-bictegravir-administered-twice-daily-combinationrifampin. Accessed May 29, 2018.. [7486]

Custodio J, West S, Vu A, et al., Pharmacokinetics of bictegravir administered twice daily with rifampin. Paper presented at: The Conference on Retroviruses and Opportunistic Infections (CROI); 2018; Boston, MA. Available from: http://www.croiconference.org/sessions/ pharmacokinetics-bictegravir-administered-twice-daily-combinationrifampin. Accessed May 29, 2018.. [7487]

Custodio JM. J Clin Pharmacol. Jun 2014; 54(6): 649-56 Pubmed [6670]

Custodio JM. Pharmacol Res Perspect. Oct 2017; 5(5) Pubmed, Volltext, DOI [7437]

Custodio, West S, Vu A, et al., Pharmacokinetics of bictegravir administered twice daily with rifampin. Paper presented at: The Conference on Retroviruses and Opportunistic Infections (CROI); 2018; Boston, MA. Available from: http://www.croiconference.org/sessions/ pharmacokinetics-bictegravir-administered-twice-daily-combinationrifampin. Accessed May 29, 2018.. [7483]

Custodio, West S, Vu A, et al., Pharmacokinetics of bictegravir administered twice daily with rifampin. Paper presented at: The Conference on Retroviruses and Opportunistic Infections (CROI); 2018; Boston, MA. Available from: http://www.croiconference.org/sessions/ pharmacokinetics-bictegravir-administered-twice-daily-combinationrifampin. Accessed May 29, 2018.. [7484]

Custodio, West S, Vu A, et al., Pharmacokinetics of bictegravir administered twice daily with rifampin. Paper presented at: The Conference on Retroviruses and Opportunistic Infections (CROI); 2018; Boston, MA. Available from: http://www.croiconference.org/sessions/ pharmacokinetics-bictegravir-administered-twice-daily-combinationrifampin. Accessed May 29, 2018.. [7485]

Cuthbert MF. Br J Pharmacol. Oct 1971; 43(2): 471P-472P Pubmed, Volltext [2360]

Cutler AJ. CNS Spectr. Feb 2018; 23(1): 39-50 Pubmed [4906]

Cutler NR. Prog Neuropsychopharmacol Biol Psychiatry. Jan 1984; 8(2): 277-83 Pubmed [1428]

Cuzzolin L. Expert Opin Drug Metab Toxicol. Aug 2018; 14(8): 855-868 Pubmed [7824]

Cvetkovic RS. Drugs. Jan 2003; 63(8): 769-802 Pubmed [5850]

Cymbalta®,Fachinformation, Stand der Information Dez. 2012 [3594]

Cysneiros RM. Clin Pharmacol Ther. Jul 2007; 82(1): 54-62 Pubmed [2507]

Czuczwar M. Pol J Pharmacol. Sep 2003; 55(5): 799-802 Pubmed [759]

Czuczwar SJ. Expert Opin Drug Metab Toxicol. Feb 2009; 5(2): 131-6 Pubmed [9278]

Czyrak A. Arzneimittelforschung. Feb 1994; 44(2): 113-8 Pubmed [11064]

D. Schmidt, G. Eckermann, U. Fuhr, G. Luef, B.J. Steinhoff, C.E.Elger, Arzneimittelinteraktionen bei der medikamentösen Epilepsietherapie: ein kritischer Überblick, Nervenheilkunde (Nov. 2007) [2766]

D. Schmidt, G. Eckermann, U. Fuhr, G. Luef, B.J. Steinhoff, C.E.Elger. Nervenheilkunde 2007; 26(11): 969-980. Nov 2007; 26(11): 969-980 Pubmed [12553]

D. Schmidt, G. Eckermann, U. Fuhr, G. Luef, B.J. Steinhoff, C.E.Elger. Nervenheilkunde 2007; 26(11): 969-980. Nov 2007; 26(11): 969-980. Nov 0207; 26(11): 969-980 Pubmed [12554]

D'Arrigo C. Pharmacol Res. Dec 2005; 52(6): 497-501 Pubmed [2687]

D'Cunha R. Biopharm Drug Dispos. Oct 2016; 37(7): 397-408 Pubmed [7615]

D'Elia C. Urol Int. Oct 2019; : 1-6 Pubmed [8118]

D'Emanuele A. Adv Drug Deliv Rev. Dec 2005; 57(15): 2147-62 Pubmed [13033]

D'Onofrio F. Neurol Sci. May 2017; 38(Suppl 1): 117-120 Pubmed [11550]

Da Rocha et al. (2008) Rev Bras Psiquiatr 30:400-401 [2881]

Da-Rocha MA Jr. J Psychopharmacol. Jan 1997; 11(3): 211-8 Pubmed [13727]

Daali Y. Metabolism. Nov 2011; 60(11): 1584-9 Pubmed [8180]

Oops!

Literaturverzeichnis